In addition, the PRKCDBP methylation levels between tumor tissues and para-tumor tissues were statically significant in female patients, suggesting PRKCDBP methylation should be a more sensitive biomarker for female NSCLC patients. Here, CAVIN3 is linked to non-small cell lung carcinoma.